Outcomes of antiretroviral therapy in children in Asia and Africa: A comparative analysis of the IeDEA pediatric multiregional collaboration

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 2, 2013, Pages 208-219

  Leroy, Valeriane ^a,b   Malateste, Karen ^a,b   Rabie, Helena ^c   Lumbiganon, Pagakrong ^d   Ayaya, Samuel ^e   Dicko, Fatoumata ^f   Davies, Mary Ann ^g   Kariminia, Azar ^h   Wools Kaloustian, Kara ⁱ   Aka, Edmond ^j   Phiri, Samuel ^k   Aurpibul, Linda ^l   Yiannoutsos, Constantin ^m   Signaté Sy, Haby ⁿ   Mofenson, Lynne ^a,h   Dabis, François ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d KHON KAEN UNIVERSITY   (Thailand)

^e MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^f HÔPITAL GABRIEL TOURÉ   (Mali)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ INDIANA UNIVERSITY   (United States)

^j CePReF   (Côte d’Ivoire)

^k LIGHTHOUSE TRUST   (Malawi)

^l CHIANG MAI UNIVERSITY   (Thailand)

^m Hopital d'Enfants Albert Royer Dakar   (Senegal)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

Africa; antiretroviral therapy; Asia; children; cohort studies; HIV infection; loss to follow up; low income countries; mortality

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; AFRICA; ANTIVIRAL THERAPY; ARTICLE; ASIA; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD MORTALITY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SERODIAGNOSIS; SOUTH AFRICA; SURVIVAL RATE; TREATMENT OUTCOME; WEST AFRICA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AFRICA, EASTERN; AFRICA, SOUTHERN; AFRICA, WESTERN; AGE FACTORS; ANTI-RETROVIRAL AGENTS; ASIA; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT; INTERNATIONAL COOPERATION; LOST TO FOLLOW-UP; MALE; REVERSE TRANSCRIPTASE INHIBITORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84872874429     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827b70bf     Document Type: Article

References (41)

1. World Health Organisation, UN AIDS, UNICEF. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access, Progress Report. Geneva, Switzerland: WHO, UNAIDS, UNICEF; 2011.
2. Davies MA, Moultrie H, Eley B, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa - the IeDEA Southern Africa collaboration. J Acquir Immune Defic Syndr. 2011;56:270-278.
3. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960. (Pubitemid 44427613)
4. UNAIDS. Global report. UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2010.
5. Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Cote d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490-491.
6. Arrive E, Kyabayinze DJ, Marquis B, et al. Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDSART- LINC) collaboration. Int J Epidemiol. 2008;37:474-480. (Pubitemid 351803999)
7. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1889.
8. Davies MA, Keiser O, Technau K, et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
9. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18:1905-1913. (Pubitemid 39313206)
10. George E, Noel F, Bois G, et al. Antiretroviral therapy for HIV- 1-infected children in Haiti. J Infect Dis. 2007;195:1411-1418. (Pubitemid 46717458)
11. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis. 2005;41:100-107. (Pubitemid 40863751)
12. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:13.
13. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011;8:e1001044.
14. Sauvageot D, Schaefer M, Olson D, et al. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children, 5 years of age. Pediatrics. 2010;125:e1039-e1047.
15. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2004; 35:320-323. (Pubitemid 38280660)
16. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4:e5790.
17. Williams PL, Van Dyke R, Eagle M, et al. Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. Am J Epidemiol. 2008;167:1375-1386. (Pubitemid 351770559)
18. World Health Organisation. HIV prevention and treatment guidelines. Antiretroviral therapy of HIV infection in infants and children in resourcelimited settings, towards universal access: recommendations for a public health approach (2006 version). Geneva, Switzerland: WHO; 2006.
19. Nash D, Farr A, McKaig R, et al. Characteristics of HIV care and treatment programs in the International epidemiologic Databases to Evaluate AIDS (IeDEA) collaboration. TULBPE053 Sixth IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, Italy, July 17-20, 2011.
20. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430. (Pubitemid 46730255)
21. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40:381-387. (Pubitemid 47202424)
22. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 2010;45:1388-1395.
23. Hosmer D, Lemeshow S. Model-building strategies and methods for logistic regression. Applied Logistic Regression. 2nd ed. Wiley & sons; 2000: 92-99.
24. Newell ML, Coovadia H, Cortina Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243. (Pubitemid 39311344)
25. The Cross Continents Collaboration for Kids. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
26. Fenner L, Brinkhof MW, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524-532.
27. Ekouevi DK, Azondekon A, Dicko F, et al. 12-Month mortality and lossto-program in antiretroviral-treated children: the IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health. 2011;11:519.
28. Lumbiganon P, Kariminia A, Aurpibul L, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56:365-371.
29. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567. (Pubitemid 351931216)
30. Yoder RB, Nyandiko WM, Vreeman RC, et al. Long-term impact of the Kenya postelection crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya. J Acquir Immune Defic Syndr. 2012;59:199-206.
31. Braitstein P, Songok J, Vreeman R, et al. 'Wamepotea' (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr. 2011;57:e40-e46.
32. Egger M, Spycher BD, Sidle J, et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med. 2011;8:e1000390.
33. Vreeman RC, Nyandiko WM, Ayaya SO, et al. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS. 2010;24:639-649.
34. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995; 142:1255-1264. (Pubitemid 26006424)
35. World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. Geneva, Switzerland: WHO; 2010.
36. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-2244.
37. Geng EH, Nash D, Kambugu A, et al. Retention in care among HIVinfected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234-244.
38. Bemelmans M, van den Akker T, Ford N, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health. 2010;15:1413-1420.
39. McCollum ED, Preidis GA, Kabue MM, et al. Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study. PLoS ONE. 2010;5:e9626.
40. Reddi A, Leeper SC. Antiretroviral therapy adherence in children: outcomes from Africa. AIDS. 2008;22:906-907. (Pubitemid 351563844)
41. Leeper SC, Montague BT, Friedman JF, et al. Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions.J Int AIDS Soc. 2010;13 (suppl2):S3.